Antiretroviral treatment for HIV infection/aids and the risk of developing hyperglycemia and hyperlipidemia

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 49, Issue 2, 2007, Pages 73-78

  De Araújo, Paulo Sérgio Ramos ^c   Ximenes, Ricardo Arraes De Alencar ^c   Lopes, Carlos Frederico Costa ^c   Duarte, João Yure ^c   Da Silva, Mecleine Mendes ^a   Carneiro, Edmilda Marques ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Hospital Corrreia Picanço   (Brazil)

^c NONE

Author keywords

AIDS; Antiretroviral therapy; Dyslipidemia; HAART; Hyperglycemia

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; CREATININE; GLUCOSE; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD SAMPLING; BRAZIL; CD4+ T LYMPHOCYTE; CHI SQUARE TEST; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; INTERVIEW; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; QUESTIONNAIRE; RISK ASSESSMENT; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD;

EID: 34248392637     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/s0036-46652007000200002     Document Type: Article

References (23)

1. BANDEIRA, F.; MACEDO, G.; CALDAS, G.; GRIZ, L. & FARIA, M. - Diabetes mellitus tipo 2. In. _ Endocrinologia. Diagnóstico e tratamento. Rio de Janeiro, MEDSI, 1998. p. 151-161.
2. BARTLETT, J.G. - Toxicity of antiretroviral agents. Hopkins HIV Rep., 11: 2-12,1999.
3. CARR, A. & COOPER, D.A. - Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor. New Engl. J. Med., 339: 1296, 1998.
4. CARR, A.; SAMARAS, K.; CHISHOLM, D.J. & COOPER, D.A. - Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet, 351: 1881-1883, 1998.
5. CARR, A.; SAMARAS, K.; THORISDOTTIR, A. et al. - Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hiperlipidaemia, and diabetes mellitus: a cohort study. Lancet, 353: 2093-2099, 1999.
6. CHURCHILL, D.R.; PYM, A.S.; BABIKER, A.G.; BACK, D.J. & WEBER, J. N. - Hyperlipidaemia following treatment with protease inhibitors in patients with HIV-1 infection. J. Clin. Pharmacol., 46: 518-519, 1998.
7. DONG, K.L.; BAUSSERMAN, L.L.; FLYNN, M.M. et al. - Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J. Acquir. Immune Defic. Syndr., 21: 107-113, 1999.
8. DUBÉ, M.P.; JOHNSON, D.L.; CURRIER, J.S. & LEEDOM, J.M. - Protease inhibitorassociated hyperglycaemia. Lancet, 350: 713-714, 1997.
9. GERVASONI, C.; RIDOLFO, A.L.; TRIFIRÒ, G. et al. - Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS, 13: 465-471, 1999.
10. HENGEL, R.L.; WATTS, N.B. & LENNOX, J.L. - Benign symmetric lipomatosis associated with protease inhibitors. Lancet, 350: 1596, 1997.
11. HERRY, I.; BERNARD, L.; TRUCHIS, P. & PERRONNE, C. - Hypertrophy of the breasts in a patient treated with indinavir. Clin. infect. Dis., 25: 937-938, 1997.
12. LO, J.C.; MULLIGAN, K.; TAI, V.W.; ALGREN, H. & SCHAMBELAN, M. - "Buffalo hump" in men with HIV-1 infection. Lancet, 351: 867-870, 1998.
13. MAGRO, D.O.; MORAES, M.J.; MOREIRA-FILHO, D.C. & PEDRO, R.J. - Lipodistrofia e dislipidemia na infecção pelo HIV/AIDS. Uma breve revisão. J. bras. AIDS, 1: 14-18, 2000.
14. MALLAL, S.A.; JOHN, M.; MOORE, C.B.; JAMES, I.R. & McKINNON, E.J. - Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS, 14: 1309-1316, 2000.
15. MAUSS, S.; WOLF, E. & JAEGER, H. - Impaired glucose tolerance in HIV-positive patients receiving and those not receiving protease inhibitors. Ann. intern. Med., 130: 162-163, 1999.
16. PERIARD, D.; TELENTI, A.; SUDRE, P. et al. - Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV cohort study. Circulation, 100: 700-705, 1999.
17. ROBERTS, A.D.; MUESING, R.A.; PARENTI, D.M. et al. - Alterations in serum levels of lipid and lipoproteins with indinavir therapy for human immunodeficiency virus-infected patients. Clin. infect. Dis., 29: 441-443, 1999.
18. SAFRIN, S. & GRUNFELD, C. - Fat distribution and metabolic changes in patients with HIV infection. AIDS, 13: 2493-2505, 1999.
19. SAINT-MARC, T.; PARTISANI, M.; POIZOT-MARTIN, I. et al. - A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS, 13: 1659-1667, 1999.
20. SEGERER, S.; BOGNER, J.R.; WALLI, R.; LOCH, O. & GOEBEL, F.-D. - Hyperlipidemia under treatment with proteinase inhibitors. Infection, 27: 77-81, 1999.
21. SULLIVAN, A.K. & NELSON, M.R. - Marked hyperlipidaemia on ritonavir therapy. AIDS, 11: 938-939, 1997.
22. TSIODRAS, S.; MANTZOROS, C.; HAMMER, S. & SAMORE, M. - Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch. intern. Med., 160: 2050-2056, 2000.
23. VIRABEN, R. & AQUILINA, C. - Indinavir-associated lipodystrophy. AIDS, 12: 37-39, 1998.